CbdMD Net Income Over Time
| YCBD Stock | USD 0.78 0.08 11.43% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CbdMD Performance and CbdMD Correlation. Will Pharmaceuticals sector continue expanding? Could CbdMD diversify its offerings? Factors like these will boost the valuation of CbdMD. Anticipated expansion of CbdMD directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CbdMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.51 | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
cbdMD Inc's market price often diverges from its book value, the accounting figure shown on CbdMD's balance sheet. Smart investors calculate CbdMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CbdMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare cbdMD Inc and related stocks such as Biofrontera, Evoke Pharma, and Sunshine Biopharma Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BFRI | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (37.7 M) | (640 K) | (20.1 M) | (17.8 M) | (16 M) | (16.8 M) |
| EVOK | (2.4 M) | (2.4 M) | (2 M) | (2.8 M) | (13.2 M) | (12.1 M) | (10.7 M) | (12.2 M) | (7.6 M) | (7.1 M) | (13.2 M) | (8.5 M) | (8.2 M) | (7.8 M) | (5.4 M) | (4.8 M) | (5.1 M) |
| SBFM | (13.1 K) | (556.2 K) | (708 K) | (2.5 M) | (1.9 M) | (1.7 M) | (3.5 M) | (1 M) | (2.2 M) | (1.7 M) | (2.8 M) | (12.4 M) | (26.7 M) | (4.5 M) | (5.1 M) | (4.6 M) | (4.9 M) |
| SNOA | (167 K) | (7.3 M) | (5.4 M) | 3.7 M | (8.2 M) | (10.2 M) | 9.3 M | (14.3 M) | (11.8 M) | (3.3 M) | (4 M) | (5.1 M) | (5.2 M) | (4.8 M) | (3.5 M) | (4 M) | (4.2 M) |
| MHUA | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 15.4 M | 19 M | 20 M | 6.2 M | 11.6 M | 10.8 M | 9.8 M | 11.3 M |
| NRSN | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (2.8 M) | (4 M) | (12.3 M) | (10.1 M) | (10.2 M) | (9.2 M) | (9.6 M) |
| SSKN | (2.3 M) | (20.4 M) | (22.7 M) | (25.9 M) | (16 M) | (27.9 M) | (3.3 M) | (21.5 M) | (4 M) | (3.8 M) | (4.4 M) | (2.7 M) | (5.5 M) | (10.8 M) | (10.1 M) | (9.1 M) | (9.5 M) |
| CDIO | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (620.4 K) | (4.7 M) | (8.4 M) | (8.4 M) | (7.5 M) | (7.2 M) |
cbdMD Inc and related stocks such as Biofrontera, Evoke Pharma, and Sunshine Biopharma Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in cbdMD Inc financial statement analysis. It represents the amount of money remaining after all of cbdMD Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| cbdMD Inc | YCBD |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2101 Westinghouse Blvd, |
| Exchange | NYSE MKT Exchange |
USD 0.78
Check out CbdMD Performance and CbdMD Correlation. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
CbdMD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.